Amneal Pharmaceuticals (AMRX) Property, Plant & Equipment (Net) Growth (3y) (2020 - 2026)
Amneal Pharmaceuticals (AMRX) Property, Plant & Equipment (Net) Growth (3y) (2020 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PP&E (Net) Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | 5.84% |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | -11.73% |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | 7.65% |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | 0.86% |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | 27.15% |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | -6.48% |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | 11.32% |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 11.90% |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | 28.35% |
| 10 | Amneal Pharmaceuticals | 5.70 Bn | 5.57 Bn | 334.51 Mn | -0.16% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -0.16% |
| Mar 31, 2026 | -1.31% |
| Dec 31, 2025 | -1.94% |
| Sep 30, 2025 | -2.56% |
| Jun 30, 2025 | -3.08% |
| Mar 31, 2025 | -5.17% |
| Dec 31, 2024 | -6.16% |
| Sep 30, 2024 | -2.12% |
| Jun 30, 2024 | -3.16% |
| Mar 31, 2024 | -2.27% |
| Dec 31, 2023 | -2.15% |
| Sep 30, 2023 | -0.77% |
| Jun 30, 2023 | -0.10% |
| Mar 31, 2023 | -0.35% |
| Dec 31, 2022 | -0.57% |
| Sep 30, 2022 | -1.42% |
| Jun 30, 2022 | -1.63% |
| Mar 31, 2022 | -0.88% |
| Dec 31, 2021 | -1.87% |
| Sep 30, 2021 | -6.78% |